Crystal Structure of Cruzain in complex with the non-covalent inhibitor Nequimed176
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Crystal Structure of Cruzain in complex with the non-covalent inhibitor Nequimed176
应用场景：
创建时间：
2024-10-16
相关数据集
Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure–Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments
Neglected tropical diseases (NTDs) make up a diverse group of debilitating illnesses disproportionately affecting impoverished communities in tropical and subtropical regions. Despite their significan
Figshare2025-08-11 更新60
Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain
Gallinamide A, originally isolated with a modest antimalarial activity, was subsequently reisolated and characterized as a potent, selective, and irreversible inhibitor of the human cysteine protease
NIAID Data Ecosystem20
Crystal structure of Trypanosoma cruzi glucokinase in complex with inhibitor HPOP-GlcN
Crystal structure of Trypanosoma cruzi glucokinase in complex with inhibitor HPOP-GlcN
NIAID Data Ecosystem10
Chagas Disease Drug Discovery: Multiparametric Lead Optimization against Trypanosoma cruzi in Acylaminobenzothiazole Series
Acylaminobenzothiazole hits were identified as potential inhibitors of Trypanosoma cruzi replication, a parasite responsible for Chagas disease. We selected compound 1 for lead optimization, aiming to
Figshare2019-10-28 更新20
Data_Sheet_2_Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake.XLSX
Chagas disease is a neglected tropical disease endemic to Latin America, though migratory movements have recently spread it to other regions. Here, we have applied a cascade virtual screening campaign
NIAID Data Ecosystem10
